Navigation Links
Anpath Group, Inc. Announces Intent To Seek Shareholder Approval for a Reverse Split of Its Common Stock

MOORESVILLE, N.C., March 19 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board : ANPG), reported today that it plans to seek shareholder approval for a reverse split of its Common Stock, which it currently anticipates will be in the range of a 1 for 7 split. If the reverse stock split is approved, each holder of Anpath's Common Stock on the date of effectiveness of the reverse stock split will be entitled to receive one share of new Common Stock in exchange for every seven shares of old Common Stock held by such person. The reverse stock split will be affected by filing a Certificate of Amendment with the Secretary of State of Delaware.

President & CEO of Anpath Group, Inc., J. Lloyd Breedlove stated, "We believe that reducing the number of outstanding shares will make our capital structure more attractive to potential investors and provide us with greater flexibility in structuring financing and pursuing other corporate development opportunities. Also, we believe that a reduction in the number of outstanding shares may make our business more attractive to potential merger, joint venture and acquisition candidates."

"Further, we believe that our current low stock price negatively affects the marketability of our Common Stock and our ability to raise additional capital," Mr. Breedlove continued. "Although we cannot guarantee it, we hope that the reverse split will result in an increase in the market price of our common stock and encourage interest in our stock and possibly promote greater liquidity for our shareholders."

About Anpath Group, Incorporated:

Anpath Group, Inc. (Anpath), through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment. Visit for more information.

EnviroSystems, Inc. is focused on safe infection prevention technologies that the company believes will position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks -- both natural and man-made. Visit for more information.

Forward Looking Statements:

This release contains forward-looking statements, which reflect expectation or belief by Anpath Group, Inc. concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to EPA and state registration of Anpath Group's products, Anpath Group's ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in Anpath Group's filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date.

SOURCE Anpath Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Anpath Group, Inc. Expands International Distribution With Minntech Corporation
2. Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors
3. Anpath Group, Inc. Announces Advancements with Animal Care Line
4. Askesis Development Group, Inc. Launches New Behavioral Health Software for Electronic Medical Records (EMR) and Practice Management
5. Polymer Group, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call
6. MiMedx Group, Inc. Adds Parker H. Pete Petit as Chairman of the Board of Directors, President, and Chief Executive Officer
7. Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008
8. The Ensign Group, Inc. Reports Fourth Quarter 2008 Earnings of $0.38 per Share; Issues 2009 Guidance
9. China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results
10. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
11. PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... Lake, IL (PRWEB) , ... November 25, 2015 , ... ... to announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto and ... case Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for the ... of the benefits of Botox® in the treatment of moderate facial wrinkling, few have ... pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism (the ...
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... In an ongoing ... Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its ... surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 at ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... November 25, 2015 Kitov Pharma ... (TASE: KTOV), a biopharmaceutical company focused on the development ... clinical conditions, today announced the closing of its previously ... ( ADSs ), each representing 20 ordinary shares of ... ADSs. The ADSs and warrants were issued in a ...
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... today announced that Chief Executive Officer Antonius Schuh, Ph.D., ... 27 th Annual Piper Jaffray Healthcare Conference. ... the New York Palace Hotel in New ... 1:30 p.m. EST. Mr. Schuh will be available for ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
Breaking Medicine Technology: